Swapnil Bhargava
Director Técnico/Científico/I+D en CG ONCOLOGY, INC. .
Perfil
Swapnil Bhargava is currently the Chief Technical Officer at CG Oncology, Inc. He previously worked as the SVP-CMC Development & GMP Manufacturing at AbCellera Biologics, Inc. and as the VP-Drug Substance Process Development at Seagen Inc. Dr. Bhargava holds a doctorate degree from the University of Maryland and a graduate degree from the Indian Institute of Technology Delhi.
Cargos activos de Swapnil Bhargava
| Empresas | Cargo | Inicio |
|---|---|---|
| CG ONCOLOGY, INC. | Director Técnico/Científico/I+D | 01/09/2023 |
Antiguos cargos conocidos de Swapnil Bhargava.
| Empresas | Cargo | Fin |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - |
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | - |
Formación de Swapnil Bhargava.
| University of Maryland | Doctorate Degree |
| Indian Institute of Technology Delhi | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Swapnil Bhargava
